In this study we wanted to confirm and expand what has been established in the literature by characterizing proinflammatory cytokines (IL-1β, TNF-α and IL-6) as well as IL-17A as inflammatory biomarkers of TMD. This evidence concerns the gene IL17A and temporomandibular joint disorder.